13F-HR filed by Saturn V Capital Management LP
Saturn V Capital Management LP filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 20 holding rows worth $238,925,068.
- Accession
- 0001964437-23-000007
- Filer
- CIK 1964437
- Filed
- 2023-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 20 entries on the cover page, a total value of $238,925,068 stated on the cover page (in dollars after the unit check, H1), rows summing to $238,925,068 with VALUE read as dollars as filed, 13F file number 028-22863. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 1,126,579 | $33,504,459 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 1,810,246 | $17,432,669 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,775,415 | $17,310,296 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,124,459 | $16,765,684 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 64,676 | $16,622,379 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 886,143 | $16,225,278 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 495,168 | $14,587,649 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 118,401 | $14,352,569 | dollars as filed | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 111,045 | $12,846,796 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 807,969 | $11,731,710 | dollars as filed | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 994,756 | $10,892,578 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 112,473 | $10,531,972 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 577,101 | $10,364,734 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 109,685 | $9,704,929 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 1,219,093 | $9,094,434 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 982,458 | $6,955,803 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 10,074 | $4,952,681 | dollars as filed | |
| MORPHIC HLDG INC | 61775R105 | COM | 136,743 | $3,132,782 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871103 | COM | 1,387,015 | $970,910 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 40,066 | $944,756 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001964437-23-000007 | this filing | 2023-11-14 | acceptance time not in the bulk data set |